oxazolidin-2-one has been researched along with Long QT Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Conrad, T; Gu, K; Kankam, M; Mueller, J; Nakamura, A; Newman, LM; O'Donnell, J; Osborn, BL; Saviolakis, GA | 1 |
| Cao, G; Chen, Y; Guo, B; Ni, K; Qian, J; Wang, L; Wang, Y; Wu, H; Wu, J; Wu, X; Xi, Y; Yu, J; Yuan, H; Zhang, J | 1 |
| Knorr, JP; Moshfeghi, M; Sokoloski, MC | 1 |
2 trial(s) available for oxazolidin-2-one and Long QT Syndrome
| Article | Year |
|---|---|
Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults.
Topics: Adult; Barbiturates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Gonorrhea; Healthy Volunteers; Heart Rate; Humans; Isoxazoles; Long QT Syndrome; Morpholines; Oxazolidinones; Spiro Compounds | 2021 |
Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers.
Topics: China; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome; Oxazolidinones; Pyridones | 2020 |
1 other study(ies) available for oxazolidin-2-one and Long QT Syndrome
| Article | Year |
|---|---|
Ciprofloxacin-induced Q-T interval prolongation.
Topics: Abscess; Acetamides; Adolescent; Anti-Infective Agents; Aztreonam; Bradycardia; Ciprofloxacin; Crohn Disease; Humans; Infusions, Intravenous; Linezolid; Long QT Syndrome; Male; Metronidazole; Oxazolidinones; Randomized Controlled Trials as Topic | 2008 |